News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

NANTKWEST (NK) GUARDIAN HEALTH Revlimid (lenolidamide) OSI (OSIP) TOKAI (TKAOI) Biocryst (BCRX) Genentech Intercept (ICPT) Alnylam (ALNY) Sanofi (SNA) Vertex (VRTX) ACADIA (ACAD) SUNESIS PHARMACEUTICALS (SNSS) INNOVIVA (INVA) Human Longevity (HLI) RenenxBio (RGNX) CompuGen (CGEN) ABBVIE (ABBV) Agenus (AGEN) GlaxoSmithKline (GSK) Velcade (bortezomib) Adaptimmune (ADAP) MODERNA NEKTAR (NKTR)) Idenix (IDIX) Agenus (AGEN ImmunoGen (IMGN) Ocular Therapeutix (OCUL) Array Pharmaceuticals (ARRY) Inovio (INO) Vitae Pharmaceuticals (VTAE) Ariad (ARIA) Auspex (ASPX) ARCA (ABIO) Ziofpharm (ZIOP) Multiple Myeloma Micromet (MITI) Amgen (AMGN) Prosensa (RNA) ADVENTRIX (ANX) ARGOS (ARGS) Roche (RHHBY) Galena (GALE) Dynavax (DVAX) ISIS (ISIS) Aimmune Therapeutics (AIMT) Incyte (INCY) CEMPRA (CEMP) Gilead (GILD) Alder Biopharmaceuticals (ALDR) Sangamo (SGMO) Biogen Idec (BIIB) VANDA (VNDA) Anacor (ANAC) C4 Therapeutics Human Genome Sciences (HGSI) Sequenom (SQNM) Intrexon (XON) Roche (ROCHE) REGULUS (RGLS) Illumina (ILMN) Zerenex KITE (KITE) PTC Therapeutics (PTCT) PORTOLA (PTLA) NOVOCURE (NVCR) Sanofi (SNY) Pluristem (PSTI) Bellicum (BLCM) Valeant Pharmaceuticals International (VRX) Regeneron (REGN) Rapamune Theravance (THRX) Prolor Biotech (PBTH) Editas (EDIT) Anadys (ANDS) BIOMARIN (BMRN) AERIE PHARMACEUTICALS Herceptin Advaxis (ADXS) Elan (ELN) Seattle Genetics (SGEN) ZALTRAP™ Onyx (ONXX) Merck (MRK) Bristol-Myers Squibb (BMY) Exelixis (EXEL) IDERA (IDRA) Abbott Laboratories (ABT) Spike Therapeutics (ONCE) Global Cell Therapeutics (GBT) AstraZeneca (AZN) Dendreon (DNDN) KERYX (KERX) SYNTA (SNTA) Sanofi-Aventis (SAN) Telaprevir Ridaforolimus Intermune (ITMN) SERES THERAPEUTICS (MCRB) Tysabri Cytokinetics (CYTK) CRISPR Therapeutics (CRSP) Endometrial Cancer HALOZYME (HALO) Xoma (XOMA) Ionis (IONS) AGOS (ARGS) Benlysta (belimumab) Mirati Therapeutics (MRTX) Theravance Bio Pharma (TBPH) JUNO (JUNO) Sarepta (SRPT) galapagos (GLPG) Trastuzumab-DM1 Jazz Pharmaceuticals (JAZZ)